Heart Failure 2018 & World Congress on Acute Heart Failure

26 - 29 May 2018, Vienna - Austria

Session Details

Poster Session 1: Chronic Heart Failure – Epidemiology, Prognosis, Outcome
Sat 26 May 08:30 - 18:00 Other Poster Session Poster Area -

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
08:30P277Nationwide trends in prevalence and incidence of and 3-year mortality in hospitalized heart failure patients in Taiwan (2010-2015): lingering hazards remainTzung-Dau WANG (Taipei City, Taiwan ROC)
08:30P278Modes of death in cardiac amyloidosisChristina BINDER (Vienna, Austria)
08:30P279Liver-specific microRNA-122 as a prognostic biomarker in patients with chronic heart failureStefan STOJKOVIC (Vienna, Austria)
08:30P280Genetics in heart failure prognosis: does it make a difference?Andrei ULITIN (St. Petersburg, Russian Federation)
08:30P281Economic impact of ivabradine use in the vulnerable phase: results from the ROCI registryClara Ines SALDARRIAGA (Medellin, Colombia)
08:30P282What is the meaning of pericardial effusion in the general population? Results from the STAAB cohort studyMargret BREUNIG (Wuerzburg, Germany)
08:30P283Outcomes are equally poor for patients with suspected heart failure and raised natriuretic peptides, regardless of whether heart failure is confirmed or excluded by a specialistAlice ZHENG (Portsmouth, United Kingdom)
08:30P284Heart failure with recovered ejection fraction in a colombian heart failure clinicClara Ines SALDARRIAGA (Medellin, Colombia)
08:30P285Sub-maximal cardiopulmonary exercise test in heart failure: which parameters should we trust?Antonio VALENTIM GONCALVES (Seia, Portugal)
08:30P286Glycemic status in non diabetic elderly hypertensives with heart failure with preserved ejection fractionLivia POPESCU (Bucuresti, Romania)
08:30P287Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: Results from ASIMILA studyFernando MANZUR JATTIN (Cartagena De Indias, Colombia)
08:30P288Serial biomarkers activity determination during NT-proBNP-guided treatment and its association with long-term clinical outcomes in patients after heart failure decompensation 
08:30P289Albumin as a prognostic marker in patients with chronic heart failure and reduced ejection fractionTatiana DUARTE (Setubal, Portugal)
08:30P290The target degree of sST2 and NT-proBNP values decrease during biomarker-guided treatment for long-term patients outcomes improvement after heart failure decompensation 
08:30P291Causes of decompensation of heart failure in patients attended in primary careJose Maria VERDU (Barcelona, Spain)
08:30P292One-year prognosis of patients with chronic heart failure, depending on AHEAD score and renal function (creatinine and NGAL).Karel LABR (Hosteradky-Resov, Czech Republic)
08:30P293Predicting readmissions in patients with heart failure: a novel and easy-to-apply scoring model Joao Pedro Ribeiro AGOSTINHO (Lisboa, Portugal)
08:30P294Long-term clinical outcome in patients with heart failure and pacemakers: a single-center cohort studyMartin RIESENHUBER (Wien, Austria)
08:30P295QRS duration is associated with outcome in symptomatic HF patients. What about ACCF/AHA stages A and B? Data from the DAVID-Berg studyAndrea POZZI (Bergamo, Italy)
08:30P296A method for predicting the survival of patients with heart failureLarisa PROKOPOVA (Saint Petersburg, Russian Federation)
08:30P297Predictors of mid-term rehospitalization and mortality rates in Bulgarian patients with heart failure and mid-range ejection fraction: a single-center study 
08:30P298Clinical presentation of heart failure in female patients-results from CRO-HF RegistryDuska GLAVAS (Split, Croatia)
08:30P299Heart failure and chronic obstructive pulmonary disease: outcome predictorsVioletta GAZIZIANOVA (Kazan, Russian Federation)